L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

When Kevin Tougher was diagnosed with nasal cavity cancer at 39, he faced the possibility of losing his nose to surgery. A groundbreaking treatment at MSK changed everything—preserving both his health ...

I am 75 and do not recall ever getting an HPV vaccine.

The research warns that a combination of lifestyle factors, late diagnosis, and the logistical struggle of accessing healthcare is costing lives. | ITV News Granada ...

A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.

Charlie endured six sessions of chemotherapy ...

In a recent column, you mentioned that the HPV (human papillomavirus) vaccine prevents neck and head cancer in men. I am 75 and do not recall ever getting an HPV vaccine. Should I get one now? -- J.L.

Lead programme based on a first-in-class small-molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV-positive head and neck cancer Programme has demonstrated strong in ...

This report highlights the socioeconomic inequalities in head and neck cancer across the UK, with those from the poorest areas disproportionately affected. According to the analysis, people in the ...

A woman says a volleyball accident revealed a rare genetic condition that leaves her with 13 tumors. McKinnon Galloway, 33, ...

People in the most socioeconomically deprived areas of the UK are more likely to die from head and neck cancer, more likely to be diagnosed at ...